[Biotech&Pharma] Top-Rated Stocks Near Buy Point With Earnings Due: Biogen

Browse By

Biogen (BIIB) is forming a base showing a 318.10 entry as it gets ready to report earnings on Jan. 30. The current formation is a first-stage flat base.


{“@context”:”https://schema.org”,”@type”:”VideoObject”,”name”:”How To Find & Track Breakout Stocks”,”description”:”Looking for stocks at or near a new buy point? Regularly check the IBD Breakout Stocks Index.”,”thumbnailUrl”:”https://www.investors.com/wp-content/uploads/2019/04/fIL2dN93-640×360.jpg”,”contentUrl”:”https://cdn.jwplayer.com/manifests/fIL2dN93.m3u8″,”uploadDate”:”2019-04-17T09:04:52+0000″,”duration”:”PT83.11S”,”author”:”Matt Galgani”,”publisher”:{“@type”:”Organization”,”name”:”Investor's Business Daily”,”logo”:{“@type”:”ImageObject”,”url”:”https://www.investors.com/wp-content/uploads/2018/09/ibd-logo.png”},”url”:”https://www.investors.com”},”keywords”:””} Be aware that buying a stock just before it reports is risky, since disappointing numbers could send it sharply lower. You can reduce your risk by waiting to see how the company reports and how the market reacts.

Looking For The Best Stocks To Buy And Watch? Start Here

The company showed 24% earnings-per-share growth last quarter, while sales growth came in at 5%.

Analysts expect earnings growth of 12% for the quarter, and 26% growth for the full year. Annual growth estimates were recently revised lower.

Biogen has a 98 Composite Rating and holds the No. 3 rank among its peers in the Medical-Biomed/Biotech industry group. Regeneron Pharmaceutical (REGN) is the No. 1-ranked stock within the group.

Note: Dates for earnings reports are subject to change. Check the company's website for any updates.


Earnings Calendar, Analyst Estimates And Stocks To Watch

New Option Strategy Limits Risk Around Earnings

Biotech And Pharmaceutical Industry And Stock News

The post Top-Rated Stocks Near Buy Point With Earnings Due: Biogen appeared first on Investor's Business Daily.

Source Investor’s Business Daily

This news is provided by Investor’s Business Daily RSS Feed, All credits go to Investor’s Business Daily. For more Investor’s Business Daily News please visit: https://www.investors.com/

Disclaimer: All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. The author is not paid to share this information. Cannabis Investment Group is not paid to share this information and has no business relationship other than shareholder with any company whose stock is mentioned in this article.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.